A new study suggests that women with diabetes can significantly reduce their risk of developing breast cancer with long-term use of low-dose aspirin. Previous research has uncovered a link between diabetes and developing breast cancer, including a 2012 study which identified a 20% increase in breast cancer among women with diabetes. Researchers have suggested the reason for this is because of changes in the body caused by diabetes, including increased inflammation and high blood glucose. To reach their findings, Dr. Yang and colleagues retrieved data from the National Health Insurance Research Database in Taiwan. They identified 148,739 women who had been diagnosed with diabetes. Over 14 years of follow-up, the researchers assessed the incidence of breast cancer among women who were taking daily low-dose aspirin, defined as 75 to 165 milligrams per day. Compared with women who did not take low-dose aspirin every day, those who did were found to have an 18% lower risk of breast cancer over 14 years.